BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23006792)

  • 1. CST6 promoter methylation in circulating cell-free DNA of breast cancer patients.
    Chimonidou M; Tzitzira A; Strati A; Sotiropoulou G; Sfikas C; Malamos N; Georgoulias V; Lianidou E
    Clin Biochem; 2013 Feb; 46(3):235-40. PubMed ID: 23006792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer.
    Kioulafa M; Balkouranidou I; Sotiropoulou G; Kaklamanis L; Mavroudis D; Georgoulias V; Lianidou ES
    Int J Cancer; 2009 Dec; 125(12):2887-92. PubMed ID: 19551853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells.
    Chimonidou M; Strati A; Tzitzira A; Sotiropoulou G; Malamos N; Georgoulias V; Lianidou ES
    Clin Chem; 2011 Aug; 57(8):1169-77. PubMed ID: 21700955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples.
    Dimitrakopoulos L; Vorkas PA; Georgoulias V; Lianidou ES
    BMC Cancer; 2012 Oct; 12():486. PubMed ID: 23088560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients.
    Agostini M; Enzo MV; Bedin C; Belardinelli V; Goldin E; Del Bianco P; Maschietto E; D'Angelo E; Izzi L; Saccani A; Zavagno G; Nitti D
    Cancer Biomark; 2012; 11(2-3):89-98. PubMed ID: 23011155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR is predictive of poor prognosis for breast cancer patients.
    Fujita N; Nakayama T; Yamamoto N; Kim SJ; Shimazu K; Shimomura A; Maruyama N; Morimoto K; Tamaki Y; Noguchi S
    Oncology; 2012; 83(5):273-82. PubMed ID: 22964822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of RASSF1A promoter methylation in operable breast cancer.
    Kioulafa M; Kaklamanis L; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Biochem; 2009 Jul; 42(10-11):970-5. PubMed ID: 19374895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer.
    Chimonidou M; Strati A; Malamos N; Georgoulias V; Lianidou ES
    Clin Chem; 2013 Jan; 59(1):270-9. PubMed ID: 23136251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer.
    Balgkouranidou I; Chimonidou M; Milaki G; Tsarouxa EG; Kakolyris S; Welch DR; Georgoulias V; Lianidou ES
    Br J Cancer; 2014 Apr; 110(8):2054-62. PubMed ID: 24642624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions.
    Rivenbark AG; Livasy CA; Boyd CE; Keppler D; Coleman WB
    Exp Mol Pathol; 2007 Oct; 83(2):188-97. PubMed ID: 17540367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
    Yamamoto N; Nakayama T; Kajita M; Miyake T; Iwamoto T; Kim SJ; Sakai A; Ishihara H; Tamaki Y; Noguchi S
    Breast Cancer Res Treat; 2012 Feb; 132(1):165-73. PubMed ID: 21594664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of free tumor-related DNA in the serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Deng GR
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):609-13. PubMed ID: 18210882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
    Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
    Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression.
    Ai L; Kim WJ; Kim TY; Fields CR; Massoll NA; Robertson KD; Brown KD
    Cancer Res; 2006 Aug; 66(16):7899-909. PubMed ID: 16912163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Xu GW; Deng GR
    Ai Zheng; 2007 Jan; 26(1):44-7. PubMed ID: 17222366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients.
    Göbel G; Auer D; Gaugg I; Schneitter A; Lesche R; Müller-Holzner E; Marth C; Daxenbichler G
    Breast Cancer Res Treat; 2011 Nov; 130(1):109-17. PubMed ID: 21221769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
    Ntoulia M; Stathopoulou A; Ignatiadis M; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Biochem; 2006 Sep; 39(9):879-87. PubMed ID: 16925986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.